Special Diabetes Program for Indians Receives $41 Million Increase for FY 2026

The U.S. Congress has reauthorized Special Diabetes Program for Indians (SDPI) funding at $200 million for fiscal year 2026, representing an increase of $41 million above the previous fiscal year's funding level. In addition, Congress provided $50 million for the first three months of FY 2027, extending authorization through December 31, 2026.

This reauthorization reflects the continued recognition of the significant impact SDPI has had in improving diabetes prevention and treatment outcomes for American Indian and Alaska Native communities.

Additionally, the Indian Health Service is awarding administrative supplements to 310 SDPI grant recipients for calendar year 2026, using one-time, unobligated SDPI funding. The supplements will be 25 percent of each recipient's annual grant award amount and will be distributed in the next few weeks.

SDPI appropriation is funded on a federal fiscal year cycle, while SDPI grants are awarded on a calendar year cycle. Current SDPI grant recipients have already received funding for the first six months of 2026, covering January 1 through June 30. The remaining annual funding for 2026 is being awarded and will be available to grant recipients on or before June 30, 2026.

Considering the additional funding provided through the FY 2026 reauthorization, the IHS is planning to conduct Tribal consultation and urban confer regarding the use of these additional SDPI funds. Information regarding this process will be forthcoming.

The IHS values our ongoing partnership with Tribes and urban Indian organizations and remains committed to supporting efforts to address diabetes-related health disparities in Native communities. For any questions or concerns, please contact Division of Diabetes Treatment and Prevention Acting Director .